Table 1.
Maximal changes in paraprotein after CC-5013 treatment
Dose, mg/d
.
No. of patients
.
Decrease
.
Increase
.
< 25%
.
≥ 25% < 50%
.
≥ 50% < 75%
.
≥ 75% < 99%
.
≥ 25%
.
5
3
0
2
1
0
0
10
5
0
0
1
0
4
25
3
1
2
0
0
0
50
13
1
6
2
3
1
Subtotal
24
2 (8%)
10 (42%)
4 (17%)
3 (13%)
5 (21%)
Dose, mg/d
.
No. of patients
.
Decrease
.
Increase
.
< 25%
.
≥ 25% < 50%
.
≥ 50% < 75%
.
≥ 75% < 99%
.
≥ 25%
.
5
3
0
2
1
0
0
10
5
0
0
1
0
4
25
3
1
2
0
0
0
50
13
1
6
2
3
1
Subtotal
24
2 (8%)
10 (42%)
4 (17%)
3 (13%)
5 (21%)
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal